Ionis Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 24 analysts polled by S&P Global, Ionis Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $105.91. The average 1-year stock price forecast is 29.47% higher than the current stock price, while the lowest is $75 (-8.31%) and the highest is $130 (+58.92%).

Price Target: $105.91 (+29.47%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$75	$105.91	$106	$130
Change	-8.31%	+29.47%	+29.58%	+58.92%

Analyst Ratings

The average analyst rating for Ionis Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	10	10	10	11	12	12
Buy	6	6	6	8	9	8
Hold	6	6	6	5	5	4
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	22	22	22	24	26	24

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Eliana Merle Barclays	Barclays	Buy Maintains $115	Buy	Maintains	$115	+40.59%	Jun 26, 2026
Jessica Fye J.P. Morgan	J.P. Morgan	Buy Reiterates $80 → $90	Buy	Reiterates	$80 → $90	+10.02%	Jun 25, 2026
Gary Nachman Canaccord Genuity	Canaccord Genuity	Buy Maintains $110	Buy	Maintains	$110	+34.47%	Jun 25, 2026
Michael Ulz Morgan Stanley	Morgan Stanley	Buy Reiterates $130	Buy	Reiterates	$130	+58.92%	Jun 25, 2026
Yanan Zhu Wells Fargo	Wells Fargo	Buy Maintains $100	Buy	Maintains	$100	+22.25%	Jun 25, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

893.41M

from 943.71M

-5.33%

from 943.71M

Revenue Next Year

1.51B

from 893.41M

68.46%

from 893.41M

EPS This Year

-2.69

from -1.54

EPS Next Year

-0.61

from -2.69

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	810.46M	587.37M	787.65M	705.14M	943.71M	893.41M
Revenue Growth	11.13%	-27.53%	34.10%	-10.48%	33.83%	-5.33%
Operating Income	-30.19M	-410.19M	-353.73M	-475.08M	-381.68M	-621.51M
Net Income	-28.60M	-269.72M	-366.29M	-453.90M	-381.39M	-598.42M
EPS	-	-	-	-	-1.54	-2.69
Free Cash Flow	76.54M	-80.22M	-173.51M	-352.83M	-154.72M	-690.76M
No. Analysts	-	-	-	-	-	23

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	947.0M
Avg	893.4M
Low	881.7M

Revenue Growth

Revenue Growth	2026	2027	2028
High	0.3%
Avg	-5.3%
Low	-6.6%

EPS Forecast

EPS	2026	2027	2028
High	-2.59
Avg	-2.69
Low	-2.79

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-